pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Vaccines · news · pharmadog
← back to Vaccines
News · Vaccines
595
stories
10d
FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk
fda press
10d
Valneva sees LimmaTech vaccine reduce Shigella infections in phase 2 test
fiercebiotech
13d
Moderna enjoys stable vaccine sales thanks to global COVID uptake
biospace
13d
Moderna notches small profit as it prioritizes work on cancer vaccines
endpoints
13d
Merck, Moderna serve 99% of trial patients with mRNA vaccine as personalized shots near market
biospace
13d
Faeth’s phase 2 data power oral combo forward in cancer targeted by ADC heavyweights
fiercebiotech
14d
FDA Grants Accelerated Approval to a New Treatment for Head and Neck Squamous Cell Carcinoma
fda press
14d
Child dies of measles in Wisconsin’s first such death since 1990
stat
14d
Head of family physician group seeks ACIP 'guardrails'
endpoints
14d
Opinion: MAHA 1.0 is dead. MAHA 2.0 is born
stat
15d
STAT+: Where does MAHA go from here? 3 possible futures
stat
15d
Biopharma likely to climb higher after ‘blue wave,’ analysts say
biopharma dive
15d
Top health takeaways from the midterm elections
stat
15d
Pfizer eyes Europe first for Lyme vaccine as prevalence rises in US
biospace
15d
Q3 earnings roll on, FDA pushes rare disease, uniQure’s Huntington’s therapy reaches review
biospace
16d
Pfizer flat in Q3 despite 32% growth for new and acquired products
biospace
16d
Child dies of measles in New York’s first such death in 30 years
stat
16d
Opinion: What the 2024 electoral map reveals about America’s mortality divide
stat
17d
FDA Provides Clarity to Support Cell and Gene Therapy Development and Quality
fda press
19d
STAT+: The 4 biggest ways the midterms could change health policy, according to policymakers, lobbyists, and experts
stat
20d
FDA Approves First Plasmid DNA-based Immunotherapy for Adults with Recurrent Respiratory Papillomatosis
fda press
20d
How Election Day can affect your heart
stat
20d
Assessing Merck and Moderna’s mRNA cancer vaccine
stat
20d
Opinion: How Congress can fix expert advisory committees
stat
20d
The health care issues STAT reporters are watching in the midterms
stat
20d
Opinion: What a mother’s 1834 letter about measles tells us about MAHA
stat
20d
Sanofi considering ‘moonshot’ treatments as M&A targets to survive Dupixent patent cliff
fiercebiotech
21d
STAT+: Kennedy’s closing arguments for the 2026 midterms: Fraud, vaccines, and MAHA
stat
21d
Martin Kulldorff critiques scientific gatekeepers at NIH lecture
stat
21d
Merck outlines 2027 as ‘another year of investment’ despite recent clinical wins
fiercebiotech
← prev
page 2 of 20
next →